Baker Biotech Capital (GP), LLC Insider Trading $SGEN Seagen Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM).

Baker Biotech Capital (GP), LLC in Seagen Inc.

Trading Symbol: SGEN
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Biotech Capital (GP), LLC: Director
Holdings: 4,966,001 shares
Current Value: $301,883,201
Latest Transaction: Jan 04 2012
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC in Seagen Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ADLR, GHDX, TZYM, PCYC, SGEN, GEVA, VPHM

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 04 2012	SGEN	SEATTLE GENETICS I ...	Baker Biotech Capital (GP), LL ...	Director	Option Exercise	X	6.25	339,788	2,123,675	0
Jan 04 2012	SGEN	SEATTLE GENETICS I ...	Baker Biotech Capital (GP), LL ...	Director	Buy	X	6.25	339,788	2,123,675	4,966,001	4.6 M to 5 M (+7.34 %)

Page: 1